Consolidated Portfolio Review Corp’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Buy |
809
+126
| +18% | +$51.1K | 0.05% | 332 |
|
|
2025
Q1 | $340K | Buy |
683
+57
| +9% | +$28.4K | 0.05% | 284 |
|
|
2024
Q4 | $326K | Buy |
626
+10
| +2% | +$5.2K | 0.05% | 282 |
|
|
2024
Q3 | $381K | Buy |
616
+29
| +5% | +$17.9K | 0.09% | 216 |
|
|
2024
Q2 | $325K | Buy |
587
+227
| +63% | +$126K | 0.08% | 225 |
|
|
2024
Q1 | $209K | Sell |
360
-71
| -16% | -$41.3K | 0.05% | 262 |
|
|
2023
Q4 | $229K | Sell |
431
-203
| -32% | -$108K | 0.05% | 265 |
|
|
2023
Q3 | $321K | Buy |
634
+147
| +30% | +$74.4K | 0.08% | 229 |
|
|
2023
Q2 | $254K | Buy |
487
+60
| +14% | +$31.3K | 0.06% | 264 |
|
|
2023
Q1 | $246K | Buy |
+427
| New | +$246K | 0.07% | 237 |
|